CAMBRIDGE, Mass. (AP) -- Genetic analysis instrument company Helicos BioSciences Corp. said Monday it signed a collaboration deal with Correlagen Diagnostics Inc., which provides genetic tests for disease diagnosis.
Financial details of the deal were not disclosed, but Correlagen bought a Helicos system. Correlagen will use Helicos' technology for genetic tests, focusing on disease areas including cardiology, endocrinology, neuropsychiatry, and immunology.
The companies will work together on sample preparation methods and data analysis.
Shares of Helicos rose 21 cents, or 8.1 percent, to $2.81 in morning trading. The stock has traded between 21 cents and $3.54 over the last 52 weeks.
Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.